Calcitonin gene-related peptide (CGRP) antagonists: blockers of neuronal transmission in migraine

被引：23

作者：

Brain, SD ^{[1
]}

机构：

[1] Kings Coll London, Ctr Cardiovasc Biol & Med, London SE1 1UL, England

来源：

BRITISH JOURNAL OF PHARMACOLOGY | 2004年 / 142卷 / 07期

关键词：

CGRP; BIBN4096BS; migraine;

D O I：

10.1038/sj.bjp.0705806

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The neuropeptide calcitonin gene-related peptide (CGRP) is a potent vasodilator that is contained in and released from sensory nerves. CGRP has been implicated in migraine, and the nonpeptide CGRP antagonist BIBN4096BS has been shown to be effective in clinical trials in migraine. To date, it has been largely assumed that the CGRP antagonist is effective due to its ability to block vasodilator activity. Goadsby and co-workers present data that now suggest that CGRP antagonists may also block neuronal transmission in migraine.

引用

页码：1053 / 1054

页数：2

共 50 条

[31] Azepino-indazoles as calcitonin gene-related peptide (CGRP) receptor antagonists
Mercer, Stephen E.
Chaturvedula, Prasad V.
Conway, Charles M.
Cook, Deborah A.
Davis, Carl D.
Pin, Sokhom S.
Macci, Robert
Schartman, Richard
Signor, Laura J.
Widmann, Kimberly A.
Whiterock, Valerie J.
Chen, Ping
Xu, Cen
Herbst, John J.
Kostich, Walter A.
Thalody, George
Macor, John E.
Dubowchik, Gene M.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 31
[32] Calcitonin gene-related peptide (CGRP) receptor antagonists: Investigations of a pyridinone template
Nguyen, Diem N.
Paone, Daniel V.
Shaw, Anthony W.
Burgey, Christopher S.
Mosser, Scott D.
Johnston, Victor
Salvatore, Christopher A.
Leonard, Yvonne M.
Miller-Stein, Cynthia M.
Kane, Stefanie A.
Koblan, Kenneth S.
Vacca, Joseph P.
Graham, Samuel L.
Williams, Theresa M.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (02) : 755 - 758
[33] CGRP and Migraine: The Role of Blocking Calcitonin Gene-Related Peptide Ligand and Receptor in the Management of Migraine
Maasumi, Kasra
Michael, Rebecca L.
Rapoport, Alan M.
DRUGS, 2018, 78 (09) : 913 - 928
[34] CGRP and Migraine: The Role of Blocking Calcitonin Gene-Related Peptide Ligand and Receptor in the Management of Migraine
Kasra Maasumi
Rebecca L. Michael
Alan M. Rapoport
Drugs, 2018, 78 : 913 - 928
[35] Quinine analogs as non-peptide calcitonin gene-related peptide (CGRP) receptor antagonists
Daines, RA
Sham, KKC
Taggart, JJ
Kingsbury, WD
Chan, J
Breen, A
Disa, J
Aiyar, N
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (20) : 2673 - 2676
[36] Lipidated Calcitonin Gene-Related Peptide (CGRP) Peptide Antagonists Retain CGRP Receptor Activity and Attenuate CGRP Action In Vivo
Jamaluddin, Aqfan
Chuang, Chia-Lin
Williams, Elyse T.
Siow, Andrew
Yang, Sung Hyun
Harris, Paul W. R.
Petersen, Jakeb S. S. M.
Bower, Rebekah L.
Chand, Shanan
Brimble, Margaret A.
Walker, Christopher S.
Hay, Debbie L.
Loomes, Kerry M.
FRONTIERS IN PHARMACOLOGY, 2022, 13
[37] Discovery and development of both intranasally and orally administered CGRP (calcitonin gene-related peptide) receptor antagonists for the treatment of migraine
Macor, John E.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
[38] Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat
Storer, RJ
Akerman, S
Goadsby, PJ
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 142 (07) : 1171 - 1181
[39] Atogepant Calcitonin gene-related peptide (CGRP) receptor antagonist Preventive treatment of migraine
Martelletti, P.
Cipolla, F.
Capi, M.
Curto, M.
Lionetto, L.
DRUGS OF THE FUTURE, 2020, 45 (05) : 265 - 277
[40] Plasma calcitonin gene-related peptide (CGRP) in migraine and endometriosis during the menstrual cycle
Raffaelli, Bianca
Overeem, Lucas Hendrik
Mecklenburg, Jasper
Hofacker, Maxi Dana
Knoth, Henriette
Nowak, Claus Peter
Neeb, Lars
Ebert, Andreas Dietmar
Sehouli, Jalid
Mechsner, Sylvia
Reuter, Uwe
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2021, 8 (06): : 1251 - 1259

← 1 2 3 4 5 →